A Safety, Tolerability, Pharmacokinetic, and Efficacy Study of Docetaxel Injection Concentrate for Nano-Dispersion (DICN) in Subjects With Unresectable Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)
Latest Information Update: 12 Nov 2019
At a glance
- Drugs Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Jul 2012 New trial record